This article is available to subscribers. Subscribe now. Already have an account? Sign in

Clinical PracticeFree Preview

Pulmonary Embolism

List of authors.
  • Susan R. Kahn, M.D.,
  • and Kerstin de Wit, M.B., Ch.B., M.D.

Evaluation of pulmonary embolism includes assessment of clinical probability and, if indicated, d-dimer testing. Most patients with low-risk pulmonary embolism can be treated with oral anticoagulants.

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.

Drs. Kahn and de Wit contributed equally to this article.

This article was updated on July 7, 2022, at NEJM.org.

Author Affiliations

From Lady Davis Institute at Jewish General Hospital and the Department of Medicine, McGill University, Montreal (S.R.K.), the Department of Emergency Medicine, Queen’s University, Kingston, ON (K.W.), and the Departments of Medicine and Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON (K.W.) — all in Canada.

Dr. Kahn can be contacted at .

Print Subscriber? Activate your online access.